Refurbished Medical Equipment Market worth 11.91 Billion USD by 2021

By -

This report studies the global refurbished medical equipment market over the forecast period of 2016 to 2021. The market is expected to reach USD 11.91 Billion by 2021, at CAGR of 12.7% from 2016 to 2021.

(EMAILWIRE.COM, May 01, 2017 ) Browse 110 market data Tables and 47 Figures spread through 208 Pages and in-depth TOC on "Refurbished Medical Equipment Market"
http://www.marketsandmarkets.com/Market-Reports/refurbished-medical-devices-market-770.html
Early buyers will receive 10% customization on this report.

On the basis of product, the global refurbished medical equipment market is divided into 11 major segments, namely, operating room equipment & surgical equipment, patient monitors, defibrillators, neurology equipment, medical imaging equipment, cardiovascular & cardiology equipment, IV therapy systems, endoscopy equipment, intensive care systems, neonatal intensive-care equipment, and other medical equipment.

The other medical equipment segment comprises blanket warmers, autoclaves, suction pumps, sequential compressor devices (SCDs), stretchers, stress test systems, heaters/coolers, dry imagers, and beds. The medical imaging equipment segment is estimated to hold the largest share of the refurbished medical equipment market in 2016.

Get The PDF Brochure For This Report@
http://www.marketsandmarkets.com/pdfdownload.asp?id=770

Key factors such as increasing privatization in the healthcare sector, poor reimbursement scenario for various medical treatments, large patient population base, and presence of a large number of hospitals/clinics with budget constraints in developing countries are the major factors driving the growth of this market. Also, growing initiatives undertaken by leading market players (such as GE Healthcare, Philips Healthcare, and Siemens Healthineers) to establish refurbishment facilities in both mature and developing markets are further adding to the growth prospects of this market.

On the other hand, the negative perception about the quality of refurbished medical devices among public institutes is a major factor limiting the growth of this market. The stringent regulatory environment in some countries (such as China, Egypt, and Kuwait) and the lack of standardization and harmonization of policies related to the sale and use of refurbished medical devices are the key challenges faced by players in the global refurbished medical equipment market.

Request for the Customization of this Report@
http://www.marketsandmarkets.com/requestCustomization.asp?id=770

As of 2016, North America holds the largest share of the global refurbished medical equipment market, followed by Europe. However, the Asia-Pacific market is expected to grow at the highest CAGR from 2016 to 2021. A number of factors such as cost containment pressures on healthcare providers, increasing patient population base, and rising number of partnerships and joint ventures among refurbished medical device providers are driving the growth of the Asia-Pacific refurbished medical equipment market.

GE Healthcare (U.S.), Koninklijke Philips N.V. (Netherlands), Siemens AG (Germany), Block Imaging International, Inc., (U.S.), Soma Technology, Inc. (U.S.), DRE Medical, Inc. (U.S.), Agito Medical A/S (Denmark), Everx Pvt Ltd. (Australia), Integrity Medical Systems, Inc. (U.S.), and Radiology Oncology Systems, Inc. (U.S.) are some of the key players operating in the refurbished medical equipment market.

About MarketsandMarkets™:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan
MarketsandMarkets™
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
Tel: 1-888-600-6441

Read other news from MarketsandMarkets™

Timing Devices Market Size, Share, Revenue Trends & Forecast to 2030

MarketsandMarkets™ - Sep 18, 2023
Timing Devices Market by Type (Oscillators, Atomic Clocks, Clock Generators, Clock Buffers, Jitter Attenuators), Material (Crystal, Silicon, Ceramic), Vertical (Consumer Electronics, Automotive) and Region - Global Forecast to 2030 ...Read more

Artificial Intelligence Market Segmented by Product, Top Manufacturers, Geography Trends & Growth Opportunity to 2030

MarketsandMarkets™ - Sep 18, 2023
Artificial Intelligence technology such as machine learning, natural language processing, computer vision, and others are revolutionizing various sectors, including healthcare, finance, manufacturing, and retail. ...Read more

Digital PCR (dPCR) and Real-time PCR (qPCR) Market worth $12.4 billion by 2028, at a CAGR of 7.8%.

MarketsandMarkets™ - Sep 18, 2023
"Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Product (Instruments, Reagents & Consumables, Software & Services), Application (Clinical, Research, Forensic), End User (Hospital, Diagnostic Labs, Pharma, Biotech, CROs) - Global Forecast to 2028". ...Read more